Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC
Clinical trial NCT04177498 · COMPLETED
Trial details
- NCT number
- NCT04177498
- Sponsor
- Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2025-05-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.